MTPConnect in conjunction with the Western Australian Government and The University of Western Australia (UWA), is delighted to announce the establishment of the Western Australian Node (the WA Node) of MTPConnect in Perth, to support the state's burgeoning life sciences sector.
MTPConnect - the Australian Government's Medical Technology, Biotechnology, and Pharmaceutical (MTP) Industry Growth Centre - is excited to support the launch of a new Australian initiative - Clinical Trials: Impact & Quality (CT:IQ), an inclusive collaboration to ensure the effective and efficient promotion of clinical trials in Australia.
MTPConnect - the Australian Government's Medical Technology, Biotechnology, and Pharmaceutical (MTP) Industry Growth Centre - is delighted to announce that it has appointed Dr Dan Grant as Chief Executive Officer.
MTPConnect – the Australian Government’s Medical Technology, Biotechnology, and Pharmaceutical (MTP) Industry Growth Centre – and the Minister for Health, the Hon Greg Hunt MP, today announced the first 11 recipients of $10 million investment from the Australian Government’s $35 million BioMedTech Horizons program.
MTPConnect - the Australian Government's Medical Technology, Biotechnology, and Pharmaceutical (MTP) Industry Growth Centre - and BioPacific Partners - an organisation helping global companies connect to Australian innovations - are jointly launching an exciting new initiative to assist Australian medical technology and pharmaceutical companies to better prepare and position themselves to engage successfully with multinational companies.
MTPConnect - the Medical Technology, Biotechnology and Pharmaceutical Industry Growth Centre - has today announced changes to the Board and Executive team for 2018.
MTPConnect has released new sector metrics that show jobs supported by the MTP sector increased by 10% to 62,000 from 2015 to 2016, and that manufacturing exports are up by 30% to $5.2 billion.
02 Nov 2017
MTPConnect and MTAA have signed an MoU further cementing their partnership to support and drive the Australian medtech industry forward.
01 Nov 2017
MTPConnect opens call for $5m BioMedTech Horizons program, supporting high-potential health breakthroughs
MTPConnect welcomes ideas that are set to customise and revolutionise healthcare, stimulate inter-disciplinary collaboration and between research, industry and technology sectors, and foster strong entrepreneurship potential for the Australian Government's $5 million BioMedTech Horizons program.
MTPConnect is focused on investing on big, bold ideas to improve the productivity, competitiveness and innovative capacity of Australia’s medtech, biotech and pharmaceutical sector.
The MoU was signed today by MTPConnect CEO Sue MacLeman and LSQ CEO Mario Pennisi at the Brisbane Convention and Exhibition Centre.
03 May 2017
Interested parties encouraged to start preparing their applications to share in the $8.2 million of available funding.
Expressions of interest are now open to take part in The Bridge Program - face-to-face and online training in the scientific, legal, financial, clinical, regulatory and reimbursement disciplines that contribute to research translation and the commercialisation of medicines.
MTPConnect today launched the final Sector Competitiveness Plan (SCP), a 10-year strategic plan to maximise the innovation, productivity and competitiveness of Australia's MTP sector.
MTPConnect and the Advanced Manufacturing Growth Centre (AMGC) have signed a memorandum of understanding (MoU) to work together in undertaking activities to accelerate the growth of advanced manufacturing in the medical technology, biotechnology and pharmaceutical (MTP) sector in Australia.